Spots Global Cancer Trial Database for hemoglobin
Every month we try and update this database with for hemoglobin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
| Clinical Tumor Anemia Registry (TAR) | NCT01795690 | Anemia | 18 Years - | iOMEDICO AG | ||
| Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer | NCT00381836 | Prostatic Neopl... Anemia | Darbepoetin Alf... | 18 Years - | University of Aarhus | |
| A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa | NCT00119613 | Small Cell Lung... | placebo darbepoetin alf... | 18 Years - | Amgen | |
| A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy | NCT00216541 | Anemia Neoplasms | epoetin alfa | 18 Years - | Janssen-Cilag B.V. | |
| Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy | NCT03619356 | Hypoxia Oxygen Deficien... Tumor Diabetes | 20 Years - | National Taiwan University Hospital | ||
| The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma | NCT00270101 | Anemia Multiple Myelom... | epoetin alfa | 40 Years - 80 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy | NCT00270127 | Anemia Cancer Neoplasm | Epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy | NCT00216541 | Anemia Neoplasms | epoetin alfa | 18 Years - | Janssen-Cilag B.V. | |
| Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer | NCT00381836 | Prostatic Neopl... Anemia | Darbepoetin Alf... | 18 Years - | University of Aarhus | |
| The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma | NCT00270101 | Anemia Multiple Myelom... | epoetin alfa | 40 Years - 80 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy | NCT00272662 | Chemotherapy In... Cancer | peginesatide | 18 Years - 80 Years | Affymax | |
| Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) | NCT01736683 | Anemia Myelodysplastic... Chronic Myelomo... Low to Intermed... Myelodysplastic... Chronic Myelomo... | Sotatercept | 18 Years - | Merck Sharp & Dohme LLC | |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy | NCT00270127 | Anemia Cancer Neoplasm | Epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma | NCT00270101 | Anemia Multiple Myelom... | epoetin alfa | 40 Years - 80 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy | NCT00261677 | Anemia Hodgkin Disease Leukemia Lymphoma, Non-h... | epoetin alfa | 5 Years - 18 Years | Ortho Biotech Products, L.P. | |
| Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins | NCT00131586 | Lung Cancer Colorectal Canc... | 18 Years - | AHS Cancer Control Alberta | ||
| A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy | NCT00283465 | Anemia Neoplasm | Epoetin alfa | 18 Years - | Janssen-Cilag B.V. | |
| Clinical Tumor Anemia Registry (TAR) | NCT01795690 | Anemia | 18 Years - | iOMEDICO AG | ||
| Safety Study of Hemospan® in Prostatectomy Patients | NCT00425334 | Blood Loss, Sur... Prostate Cancer Surgery | Hemospan (MP4OX... Ringer's lactat... | 18 Years - | Sangart | |
| Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia | NCT00338299 | Anemia Chemotherapy | Epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy | NCT00524407 | Chemotherapy Anemia Cancer | Epoetin alfa | 18 Years - | Ortho Biotech Clinical Affairs, L.L.C. | |
| Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers | NCT00097747 | Anemia Chronic Kidney ... Chronic Renal F... Cancer | Placebo peginesatide | 18 Years - 40 Years | Affymax | |
| Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins | NCT00131586 | Lung Cancer Colorectal Canc... | 18 Years - | AHS Cancer Control Alberta | ||
| Safety Study of Hemospan® in Prostatectomy Patients | NCT00425334 | Blood Loss, Sur... Prostate Cancer Surgery | Hemospan (MP4OX... Ringer's lactat... | 18 Years - | Sangart | |
| A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa | NCT00119613 | Small Cell Lung... | placebo darbepoetin alf... | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
